Literature DB >> 4433354

Significance of eosinophilia during gold therapy.

P Davis, G R Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4433354     DOI： 10.1002/art.1780170607

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  10 in total

1.  Massive eosinophilia in rheumatoid arthritis: report of four cases.

Authors:  P T Dawes; D H Smith; D L Scott
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

2.  Acute disseminated encephalomyelitis as a complication of treatment with gold.

Authors:  M Cohen; C P Day; J L Day
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20

3.  Fatal intrahepatic cholestasis and interstitial lung fibrosis following gold therapy for rheumatoid arthritis.

Authors:  M R Shaban; D N Golding; R G Letcher
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

4.  Corneal chrysiasis and clinical improvement with chrysotherapy in rheumatoid arthritis.

Authors:  P J Prouse; J J Kanski; J M Gumpel
Journal:  Ann Rheum Dis       Date:  1981-12       Impact factor: 19.103

5.  Relationship of gold and penicillamine therapy to diffuse interstitial lung disease.

Authors:  D L Scott; G V Bradby; T J Aitman; G C Zaphiropoulos; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

6.  Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.

Authors:  H J Williams; J R Ward; M J Egger; J C Reading; C O Samuelson; M Altz-Smith; R W Willkens; M A Solsky; S P Hayes; D Furst
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

7.  Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold.

Authors:  S M Wilkinson; A G Smith; M J Davis; D Mattey; P T Dawes
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

8.  Reactive arthritis with eosinophilic synovial infiltration.

Authors:  B Bissonnette; F Beaudet
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 9.  Rheumatologic disease with peripheral eosinophilia.

Authors:  Nüket Bavbek; Ayşe Kargili; Handan Cipil; Ali Koşar; Yaşar Karaaslan
Journal:  Rheumatol Int       Date:  2004-04-20       Impact factor: 2.631

10.  Eosinophilia in D-penicillamine therapy.

Authors:  D H Smith; D L Scott; G C Zaphiropoulos
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.